Celcuity Inc. Schedules Release of Third Quarter 2020 Financial Results and Conference Call

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

MINNEAPOLIS, MN / ACCESSWIRE / October 26, 2020 / Celcuity Inc. (Nasdaq:CELC), a clinical stage biotechnology company translating discoveries of new cancer sub-types into pioneering diagnostics and expanded therapeutic options for cancer patients, announced that it will release its financial results for the third quarter 2020 after the stock market close on Monday, November 9, 2020. Management will host a teleconference the same day at 4:30 p.m. Eastern Time (ET) to discuss the results.

Conference Call Details

Participants should dial 1-866-831-8616 and use passcode 33954. Participants are asked to dial in 5 to 10 minutes prior to the start of the call.

About Celcuity

Celcuity is a clinical stage biotechnology company translating discoveries of new cancer sub-types into pioneering companion diagnostics and expanded therapeutic options for cancer patients. Celcuity’s proprietary CELsignia diagnostic platform analyzes living tumor cells to untangle the complexity of the cellular activity driving a patient’s cancer. This allows Celcuity to discover new cancer sub-types molecular diagnostics cannot detect. We are driven to improve outcomes for patients and to transform how pharmaceutical companies define the patient populations for their targeted therapies. Celcuity is headquartered in Minneapolis, MN. Further information about Celcuity can be found at www.celcuity.com

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including the anticipated benefits to the clinical outcomes of cancer patients. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Celcuity, which include, but are not limited to, those set forth in the Risk Factors section of Celcuity’s Annual Report on Form 10-K for the year ended December 31, 2019. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Celcuity undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contacts:

Celcuity Inc.
Brian Sullivan, bsullivan@celcuity.com
Vicky Hahne, vhahne@celcuity.com

SOURCE: Celcuity Inc.

View source version on accesswire.com:
https://www.accesswire.com/612304/Celcuity-Inc-Schedules-Release-of-Third-Quarter-2020-Financial-Results-and-Conference-Call

Staff

Recent Posts

Danziger & De Llano Launches New Website to Better Serve Victims of Mesothelioma and Personal Injury

HOUSTON, May 30, 2025 /PRNewswire/ -- Danziger & De Llano, LLP, a Texas-based law firm with…

3 hours ago

AIxMed Partnership with Lumea Enhances Digital Pathology Platform with AI-Powered Urine Cytology Solution

Lumea and AIxMed team up to bring AI driven urine cytology to Lumea's platform, targeting…

3 hours ago

Real-World Deployments Signal AI Healthcare Is Ready for Scale

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 30,…

3 hours ago

The National Hispanic Health Foundation Begins a Bold New Chapter to Build a Sustainable Healthcare System for All

WASHINGTON, May 30, 2025 /PRNewswire/ -- The National Hispanic Health Foundation (NHHF), formerly part of the…

3 hours ago

Velsera Powers the Knowledgebase Behind Illumina’s TSO Comprehensive Test, Now Approved in Japan

BOSTON, May 30, 2025 /PRNewswire/ -- Velsera announces that its clinical Knowledgebase is powering the interpretation…

3 hours ago